Kevin C. Oboyle, Director at GenMark Diagnostics, Inc. (GNMK), sold 74,735 shares at $6.51 ($483K) on 2019-08-16, disclosed to the SEC on 2019-08-19.
Open-market sale of $483k GNMK by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.42 | 16,870 | $108K | 22.4% |
| 2 | $6.42 | 23,365 | $150K | 31.1% |
| 3 | $6.51 | 2,200 | $14K | 3.0% |
| 4 | $6.51 | 16,150 | $105K | 21.8% |
| 5 | $6.51 | 16,150 | $105K | 21.8% |
| Total | $6.46 avg | 74,735 |
| $483K |
| 100% |
| Filing → |
| SIEN | BUY | 2019-06-11 | $50K | — | Filing → |
| NVRO | BUY | 2019-06-07 | $101K | — | Filing → |
| WMGI | SELL | 2019-03-05 | $205K | — | Filing → |